FASN and cancer: In this setting, our discovery of FASN as a negative regulator of tissue architecture and terminal epithelial cell differentiation, which is dominant over the malignant phenotype of metastatic tumor cells possessing multiple cancer-driving genetic lesions [28, 56], points to an unappreciated role for endogenous lipogenesis in controlling a supra-genetic dimension critical to tumorigenesis.